These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3921688

  • 21. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
    Sznitowska M, Płaczek M, Klunder M.
    Acta Pol Pharm; 2005; 62(1):25-9. PubMed ID: 16022490
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S, Subaşi B, Vural I, Unlü N, Capan Y.
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [Abstract] [Full Text] [Related]

  • 23. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y, Hourigan JA, Sleigh RW, Steele RJ.
    Int J Pharm; 2008 Jul 09; 359(1-2):123-34. PubMed ID: 18485633
    [Abstract] [Full Text] [Related]

  • 24. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
    Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T.
    Chem Pharm Bull (Tokyo); 2006 Feb 09; 54(2):175-80. PubMed ID: 16462059
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the performance characteristics of bilayer tablets: Part II. Impact of environmental conditions on the strength of bilayer tablets.
    Kottala N, Abebe A, Sprockel O, Bergum J, Nikfar F, Cuitiño AM.
    AAPS PharmSciTech; 2012 Dec 09; 13(4):1190-6. PubMed ID: 22965660
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS, Tank J, Suryanarayanan R.
    J Pharm Sci; 2007 May 09; 96(5):1434-44. PubMed ID: 17455350
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterising surface energy of pharmaceutical powders by inverse gas chromatography at finite dilution.
    Das SC, Stewart PJ.
    J Pharm Pharmacol; 2012 Sep 09; 64(9):1337-48. PubMed ID: 22881445
    [Abstract] [Full Text] [Related]

  • 35. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol.
    Koner JS, Rajabi-Siahboomi A, Bowen J, Perrie Y, Kirby D, Mohammed AR.
    Sci Rep; 2015 Nov 10; 5():16352. PubMed ID: 26553127
    [Abstract] [Full Text] [Related]

  • 36. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I, Löbmann K, Grohganz H, Rades T, Leopold CS.
    Int J Pharm; 2018 Jun 10; 544(1):172-180. PubMed ID: 29669257
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.
    Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.